This compound is an impurity reference standard related to carfilzomib, a proteasome inhibitor. It is characterized as a pentanamide derivative containing an epoxide moiety, and it is used in pharmaceutical quality control and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing (R,R)-Epoxy Leucine Carfilzomib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-L-phenylalanine
pharmaceutical intermediate
(S)-Methyl 2-((S)-4-Methyl-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMido)-3-phenylpropanoate
pharmaceutical intermediate
Quinapyramine
pharmaceutical raw material
Upadacitinib hemihydrate
pharmaceutical raw material
Upacicalcet sodium
pharmaceutical raw material
Amifostine
cytoprotective adjuvant for chemoradiotherapy
Carfilzomib
pharmaceutical raw material
(S)-4-Methyl-N-((R)-1-(((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
pharmaceutical intermediate
(2R)-4-methyl-N-[(2S)-1-[[4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2R)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
BLMPQMFVWMYDKT-BZSRRHAESA-N
CC(C)C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)[C@]2(CO2)C)NC(=O)[C@@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
—
Sourcing (R,R)-Epoxy Leucine Carfilzomib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.